{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:28:35Z","timestamp":1793755715808,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jiac.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T22:39:12Z","timestamp":1524695952000},"page":"654-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Koji","family":"Furuuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.04.002_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","article-title":"Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease","volume":"182","author":"Winthrop","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2018.04.002_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2018.04.002_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","article-title":"Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct pre-existing syndrome","volume":"178","author":"Kim","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2018.04.002_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1378\/chest.126.2.566","article-title":"Mycobacterium avium complex pulmonary disease in patients without HIV infection","volume":"126","author":"Field","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2018.04.002_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2018.04.002_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2012.01.014","article-title":"Clinical characteristics and prognosis of chronic pulmonary aspergillosis","volume":"106","author":"Ohba","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2018.04.002_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2013.806826","article-title":"Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis","volume":"51","author":"Jhun","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.jiac.2018.04.002_bib8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1440-1843.2006.00952.x","article-title":"Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease","volume":"11","author":"Kobashi","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2018.04.002_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2018.04.002_bib10","first-page":"781","article-title":"Clinical analysis of non-tuberculous mycobacteriosis cases complicated with pulmonary aspergillosis","volume":"86","author":"Ishikawa","year":"2011","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2018.04.002_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/mmy\/myv093","article-title":"The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria","volume":"54","author":"Takeda","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.jiac.2018.04.002_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/resp.12287","article-title":"Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis","volume":"19","author":"Zoumot","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2018.04.002_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2018.04.002_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5588\/ijtld.16.0711","article-title":"Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients","volume":"21","author":"Furuuchi","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2018.04.002_bib15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jiac.2018.04.002_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1183\/09031936.06.00139005","article-title":"Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis","volume":"28","author":"Kunst","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2018.04.002_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.46.1.15","article-title":"Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease","volume":"46","author":"Palmer","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2018.04.002_bib18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1378\/chest.14-0917","article-title":"Diagnosis and treatment of pulmonary aspergillosis syndromes","volume":"146","author":"Patterson","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2018.04.002_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/infdis\/147.1.160","article-title":"Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones","volume":"147","author":"Diamond","year":"1983","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2018.04.002_bib20","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1172\/JCI112166","article-title":"Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon","volume":"76","author":"Schaffner","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jiac.2018.04.002_bib21","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1099\/13500872-140-9-2475","article-title":"Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis","volume":"140","author":"Ng","year":"1994","journal-title":"Microbiology"},{"key":"10.1016\/j.jiac.2018.04.002_bib22","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","article-title":"The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis","volume":"33","author":"Perfect","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.04.002_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2169\/internalmedicine.52.9142","article-title":"Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis","volume":"52","author":"Nakamoto","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2018.04.002_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jiac.2015.08.006","article-title":"Evaluation of clinical characteristics and prognosis of chronic pulmonary aspergillosis depending on the underlying lung diseases: emphysema vs prior tuberculosis","volume":"21","author":"Koyama","year":"2015","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18301065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18301065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:16Z","timestamp":1761159436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18301065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1341321X18301065"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.04.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}